Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2023-12-22 00:00:00 ET · period of report 2023-12-20 · accession 0001689375-23-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-22 | 2023-12-20 | TRDA | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.00 | -1,000 | 245.3K | -0.4% | -$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-20 | S | D | 1,000 | $15.00 | 245,279 | D | — | — |